Newsletter

For many of our members, the search for funding and grants is an inevitable part of growth. We are grateful to the City of San Antonio for approving a new program to support small businesses with high-growth potential.  Funding will be provided based on eligibility requirements assessed as part of an application. Limited funding support … Read more

COL Jane Shen-Gunther, M.D., is an obstetrician-gynocolgist clinician-researcher at the Brooke Army Medical Center (BAMC). Her focus is to develop simple and self-administered cancer screening tests. Much of her research has focused on the Human Papillomavirus (HPV), including the development of a highly sophisticated predictive model. In addition to improving patient care, her work has … Read more

Knowing NIH grant paylines is important information to assess whether or not your project will be funded. An NIH payline is determined based the combination of the available funds and applications for those available funds.  The Impact score is evaluated relative to the NIH payline.  The NIH payline is the cutoff for funding: an Impact Score higher … Read more

A new addition to Biofest Week this year, Biofest Tours, enabled attendees to visit 5 key assets in the San Antonio life science ecosystem: Southwest Research Institute, Texas Biomedical Research Institute, BioBridge Global, NVision, and VelocityTX.  Participants learned more about these organizations, including laboratory tours. With a full roster and a waitlist, BioMedSA welcomed participants … Read more

BioMedSA’s Board of Directors approved 2 new memberships in May 2023: iGenomeDX and Aiculus. iGenomeDx is a San Antonio based molecular diagnostic laboratory whose mission is to enhance decision-making for physicians, increase the quality of care for patients, and lower the costs of healthcare for everyone by providing reliable genetic testing services. Testing services in … Read more

The potential for tremendous growth in Bioscience Artificial intelligence (AI) is staggering with some areas expected to grow as much as 40% Compounded Annual Growth Rate (CAGR) over the next 10 years.  Potential areas of growth include: 1). Drug Discovery, 2). Genomics, 3). Medical Imaging, 4). Precision Medicine, 5). Synthetic Biology and 6). Robotics and … Read more

Biofest Invest 2023 was held on April 19, 2023, the day before the start of San Antonio’s Fiesta celebration. Over 260 people registered to attend.  Medtech, biotech, digital health, and pharma entrepreneurs made connections with investors, support organizations, and colleagues, as well as received helpful information to enable their growth.  Forty-nine sponsors across the life science … Read more

The U.S. Small Business Administration (SBA) announced San Antonio’s BioMedSA as a Stage One winner for the 2023 Growth Accelerator Fund Competition. BioMedSA will receive a $50,000 cash prize to build strategic partnerships that will support the launch, growth, and scale of bioscience startups in San Antonio and the surrounding region, serving as a model for … Read more

Bexar County Commissioners presented Heather Hanson, President of BioMedSA, a proclamation of Biofest Week. Biofest Week is a chance to celebrate San Antonio’s largest economic sector, healthcare and bioscience during the week before Fiesta. Biofest Week was started with Biofest Invest in person for the first time in 2022. Biofest Invest connects bioscience entrepreneurs with … Read more

BioMedSA’s Board of Directors approved 4 new memberships in March 2023: NewLife Medicals, Harness IP, Fukuda Denish, and Nixon Peabody. NewLife Medicals (USA), Inc. supplies Reference Listed Drugs (RLDs) to large multinational companies, Clinical Research Organizations (CROs) and clinical trial sponsors. Their US FDA registered, GDP compliant warehouse provides storage & distribution facilities.  Their storage … Read more